Sunshine Biopharma Inc. - Common Stock .0001 (SBFM)

CUSIP: 867781809

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class
Equity / Common Stock .0001
Total 13F shares
214
Total 13F value
$166
Holder snapshot 6 signals
Share change
+50
SEC-reported price per share
$0.89
Number of holders
2
Value change
+$38
Number of buys
1
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
15,165,000

Security key

867781809

Report period

Q3 2026

Institutions

2

Top holders

2

SBFM full security history Ownership snapshot Full 13F holder table Previous quarter: Q2 2026 Sunshine Biopharma Inc. SEC filings Sunshine Biopharma Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SBFM - Sunshine Biopharma Inc. - Common Stock .0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
INTRACOASTAL CAPITAL, LLC
Disclosed value leader
Malek Chamoun
Comparable rows
4/15
Latest evidence
14 Aug 2026
13D/G 3/4/5 13F Lead comparable stake: 10% 11 rows are not safely comparable across share classes. 13D/G row: INTRACOASTAL CAPITAL, LLC Showing 1-6 of 15 holder rows.

Quick read

INTRACOASTAL CAPITAL, LLC leads the comparable SEC ownership view at 10%.

4 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens INTRACOASTAL CAPITAL, LLC's linked filing trail.
Comparable ownership Top 4
INTRACOASTAL CAPITAL, LLC 10%
BIGGER CAPITAL FUND L P 9.5%
L1 Capital Global Opportunities M... 5%
Alta Partners LLC 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
INTRACOASTAL CAPITAL, LLC
13D/G
Mitchell P. Kopin
13D/G
10%
Reported 13D/G · 30 Jun 2026
$504,392
235,697 shares
 $0 30 Jun 2026
BIGGER CAPITAL FUND L P
13D/G
Bigger Michael
13D/G
9.5%
Reported 13D/G · 18 May 2026
—
1,610,000 shares
 $0 18 May 2026
L1 Capital Global Opportunities Master Fund, Ltd.
13D/G
13D/G
5%
Reported 13D/G · 14 Aug 2026
—
111,535 shares
 $0 14 Aug 2026
Alta Partners LLC
13D/G
13D/G
4.9%
Reported 13D/G · 13 Aug 2026
$224,000
200,000 shares
 $0 13 Aug 2026
Malek Chamoun
3/4/5
10%+ Owner
3/4/5
—
denominator unverified
$2,824,950
3,700,000 shares
 — 20 Oct 2022
Steve N. Slilaty
3/4/5
Chief Executive Officer, Director, 10%+ Owner
3/4/5
—
denominator unverified
$13,000
130,000 shares
 — 04 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
214
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
9
Q3 2026 holders
2
Holder diff
-7
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .